We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Shire Pharmaceuticals Group Plc is confident Canadian regulators will reverse
a decision to suspend its top-selling hyperactivity drug, since the ban is not
justified, the company's chief executive has said.
Alpharma has entered into an agreement with Orchid Chemicals & Pharmaceuticals,
a Chennai-based global pharmaceutical company, whereby Orchid will develop,
manufacture and supply generic prescription products for exclusive sale by Alpharma.
Curacyte AG, a late stage drug discovery and development company has announced
its merger with IBFB PHARMA GmbH. IBFB PHARMA is a biopharmaceutical company
engaged in discovery and development of therapeutics to treat a variety of inflammatory
diseases.
Pfizer has acquired San Diego-based Idun Pharmaceuticals, a company focused
on discovery and development of therapeutics in the area of liver disease, inflammation
and cancer.
Conceding to the industry's demand, the government
hiked the abatement limit of excise duty on the retail price of drugs to 40
percent from 35 percent at present.
Despite assurances that all medically necessary drugs must be made available
under the Medicare prescription drug benefit, the final guidelines for designing
the Rx formularies could still leave numerous drugs off the list, says a pharmaceutical
industry expert.